Abstract
Purpose
Parathyroidectomy to treat tertiary hyperparathyroidism (THPT) is now on a par with calcimimetic treatment. The effects of cinacalcet and parathyroidectomy on kidney transplant function remain controversial. The aim of this study was to evaluate kidney transplant function in THPT patients treated either by parathyroidectomy, cinacalcet, or not treated.
Methods
Between 2009 and 2019, 231 patients with functional grafts presenting THPT, defined either by calcaemia superior to 2.5 mmol/L with elevated PTH level or hypercalcaemia with non-adapted PTH level 1 year after kidney transplantation, were included. Hyperparathyroid patients treated by cinacalcet and parathyroidectomy were matched for age, sex, graft rank, and baseline eGFR with cinacalcet-only and untreated patients. Conditional logistic regression models were used to compare eGFR variations 1 year after parathyroidectomy between operated patients and matched controls. Five-year survivals were compared with the Mantel-Cox test.
Results
Eleven patients treated with parathyroidectomy and cinacalcet were matched with 16 patients treated by cinacalcet-only and 29 untreated patients. Demographic characteristics were comparable between groups. Estimated odds ratios for eGFR evolution in operated patients compared with cinacalcet-only and untreated patients were 0.92 [95%CI 0.83–1.02] and 0.99 [0.89–1.10] respectively, indicating no significant impairment of eGFR 1 year after surgery. Five-year allograft survival was not significantly impaired in operated patients.
Conclusions
Parathyroidectomy did not appear to substantially alter or improve graft function 1 year after surgery or 5-year allograft survival. It could be hypothesized that in addition to its known benefits, parathyroidectomy can be safely performed vis-à-vis graft function in tertiary hyperparathyroidism.
Similar content being viewed by others
Data availability
All data and materials are available and comply with field standards.
Code availability
All codes and software applications are available and comply with field standards.
References
Naveh-Many T, Volovelsky O (2020) Parathyroid cell proliferation in secondary hyperparathyroidism of chronic kidney disease. Int J Mol Sci 21(12):4332
Evenepoel P, Claes K, Kuypers D, Maes B, Bammens B, Vanrenterghem Y (2004) Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre study. Nephrol Dial Transplant 19(5):1281–1287
Evenepoel P (2013) Recovery versus persistence of disordered mineral metabolism in kidney transplant recipients. Semin Nephrol 33(2):191–203
Heaf J, Tvedegaard E, Kanstrup I-L, Fogh-Andersen N (2003) Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant 17(3):268–274
Heaf J, Tvedegaard E, Kanstrup I-L, Fogh-Andersen N (2000) Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14(5):457–463
Kunzendorf U, Kramer BK, Arns W, Braun J, Grossmann J, Pietruck F et al (2007) Bone disease after renal transplantation. Nephrol Dial Transplant 23(2):450–458
Serra AL, Schwarz AA, Wick FH, Marti H-P, Wüthrich RP (2005) Successful treatment of hypercalcemia with cinacalcet in renal transplant recipients with persistent hyperparathyroidism. Nephrol Dial Transplant 20(7):1315–1319
Tang JA, Friedman J, Hwang MS, Salapatas AM, Bonzelaar LB, Friedman M (2017) Parathyroidectomy for tertiary hyperparathyroidism: a systematic review. Am J Otolaryngol sept 38(5):630–635
Evenepoel P, Claes K, Kuypers D, Maes B, Vanrenterghem Y (2005) Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study. Nephrol Dial Transplant 20(8):1714–1720
Schlosser K, Endres N, Celik I, Fendrich V, Rothmund M, Fernández ED (2007) Surgical treatment of tertiary hyperparathyroidism: the choice of procedure matters! World J Surg 31(10):1947–1953
Kandil E, Florman S, Alabbas H, Abdullah O, McGee J, Noureldine S et al (2010) Exploring the effect of parathyroidectomy for tertiary hyperparathyroidism after kidney transplantation. Am J Med Sci 339(5):420–424
Parikh S, Nagaraja H, Agarwal A, Samavedi S, Visger SS, Nori U et al (2013) Impact of post-kidney transplant parathyroidectomy on allograft function. Clin Transplant 27(3):397–402
Tseng P-Y, Yang W-C, Yang C-Y, Tarng D-C (2015) Long-term outcomes of parathyroidectomy in kidney transplant recipients with persistent hyperparathyroidism. Kidney Blood Press Res 40(4):386–394
Chudzinski W, Wyrzykowska M, Nazarewski S, Durlik M, Galazka Z (2016) Does the parathyroidectomy endanger the transplanted kidney? Transplant Proc 48(5):1633–1636
Finnerty BM, Chan TW, Jones G et al (2019) parathyroidectomy versus cinacalcet in the management of tertiary hyperparathyroidism: surgery improves renal transplant allograft survival. Surgery 165(1):129–134
Frey S, Goronflot T, Kerleau C, Gourraud P-A, Caillard C, Hourmant M et al (2021) Parathyroidectomy versus cinacalcet: do we still not know the best option for graft function in kidney-transplanted patients? A meta-analysis Surgery 170(3):727–735
Rostaing L, Moreau-Gaudry X, Baron E, Cisterne JM, Monroziès-Bernadet P, Durand D (1997) Changes in blood pressure and renal function following subtotal parathyroidectomy in renal transplant patients presenting with persistent hypercalcemic hyperparathyroidism. Clin Nephrol 47(4):248–255
Lee PP, Schiffmann L, Offermann G, Beige J (2004) Effects of parathyroidectomy on renal allograft survival. Kidney Blood Press Res 27(3):191–196
Evenepoel P, Claes K, Kuypers DR, Debruyne F, Vanrenterghem Y (2007) Parathyroidectomy after successful kidney transplantation: a single centre study. Nephrol Dial Trans 22(6):1730–1737
Meng C, Martins P, Frazão J, Pestana M (2017) Parathyroidectomy in persistent post-transplantation hyperparathyroidism — single-center experience. Transplant Proc 49(4):795–798
Garcia A, Mazuecos A, Garcia T, González P, Ceballos M, Rivero M (2005) Effect of parathyroidectomy on renal graft function. Transplant Proc 37(3):1459–1461
Wüthrich RP, Martin D, Bilezikian JP (2007) The role of calcimimetics in the treatment of hyperparathyroidism. Eur J Clin Invest 37(12):915–922
Park JH, Kang S-W, Jeong JJ, Nam K-H, Chang HS, Chung WY et al (2011) Surgical treatment of tertiary hyperparathyroidism after renal transplantation: a 31-year experience in a single institution. Endoc J 58(10):827–833
Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C et al (2016) A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27(8):2487–2494
Soliman AR, Maamoun HA, Soliman MA, Darwish H, Elbanna E (2016) Cinacalcet versus parathyroidectomy in the treatment of secondary hyperparathyroidism post renal transplantation. Rom J Intern Med 54(3):184–189
Rayes N (2008) Long-term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 143(8):756
Ivarsson KM, Akaberi S, Isaksson E, Reihnér E, Rylance R, Prütz KG et al (2015) The effect of parathyroidectomy on patient survival in secondary hyperparathyroidism. Nephrol Dial Transplant 30(12):2027–2033
Ferreira GF, de Montenegro FLM, Machado DJ, Ianhez LE, Nahas WC, David-Neto E (2011) Parathyroidectomy after kidney transplantation short-and long-term impact on renal function. Clinics 66(3):431–435
Bonarek H, Merville P, Bonarek M, Moreau K, Morel D, Aparicio M et al (1999) Reduced parathyroid functional mass after successful kidney transplantation. Kidney Int 56(2):642–649
Triponez F, Clark OH, Vanrenthergem Y, Evenepoel P (2008) Surgical treatment of persistent hyperparathyroidism after renal transplantation. Ann Surg 248(1):18–30
Copley JB, Wüthrich RP (2011) Therapeutic management of post-kidney transplant hyperparathyroidism: managing post-kidney transplant HPT. Clin Transplant 25(1):24–39
Zhu X, Shan C, Zhu Q, Song L, Zhou Y, Liu J et al (2014) Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism. Int J Clin Med 7(12):5445–5452
Jeon HJ, Kim YJ, Kwon HY, Koo TY, Baek SH, Kim HJ et al (2012) Impact of parathyroidectomy on allograft outcomes in kidney transplantation. Transpl Int 25(12):1248–1256
Dulfer RR, Franssen GJH, Hesselink DA, Hoorn EJ, van Eijck CHJ, van Ginhoven TM (2017) Systematic review of surgical and medical treatment for tertiary hyperparathyroidism: Surgical and medical treatment of tertiary hyperparathyroidism. Br J Surg 104(7):804–813
Chou F-F, Hsieh K-C, Chen Y-T, Lee C-T (2008) Parathyroidectomy followed by kidney transplantation can improve bone mineral density in patients with secondary hyperparathyroidism. Transplantation 86(4):554–557
Collaud S, Staub-Zähner T, Trombetti A, Clerici T, Marangon N, Binet I et al (2008) Increase in bone mineral density after successful parathyroidectomy for tertiary hyperparathyroidism after renal transplantation. World J Surg 32(8):1795–1801
Pitt SC, Panneerselvan R, Chen H, Sippel RS (2009) Tertiary hyperparathyroidism: is less than a subtotal resection ever appropriate? A study of long-term outcomes Surgery 146(6):1130–1137
Yamamoto T, Tominaga Y, Okada M, Hiramitsu T, Tsujita M, Goto N et al (2016) Characteristics of persistent hyperparathyroidism after renal transplantation. World J Surg 40(3):600–606
Kilgo MS, Pirsch JD, Warner TF, Starling JR (1998) Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery 124(4):677–684
Jäger MD, Kaaden S, Emmanouilidis N, Lück R, Beckmann JH, Güner Z et al (2011) Effect of incomplete parathyroidectomy preserving entire parathyroid glands on renal graft function. Arch Surg 146(6):704
Schwarz A, Rustien G, Merkel S, Radermacher J, Haller H (2006) Decreased renal transplant function after parathyroidectomy. Nephrol Dial Transplant 22(2):584–591
Pimentel A, Ureña-Torres P, Zillikens MC, Bover J, Cohen-Solal M (2017) Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation. Kidney Int 92(6):1343–1355
Naylor KL, Prior J, Garg AX, Berger C, Langsetmo L, Adachi JD et al (2016) Trabecular bone score and incident fragility fracture risk in adults with reduced kidney function. Clin J Am Soc Nephrol 11(11):2032–2040
Acknowledgements
DIVAT consortium: Gilles Blancho, Julien Branchereau, Diego Cantarovich, Agnès Chapelet, Jacques Dantal, Clément Deltombe, Lucile Figueres, Claire Garandeau, Magali Giral, Caroline Gourraud-Vercel, Maryvonne Hourmant, Georges Karam, Clarisse Kerleau, Aurélie Meurette, Simon Ville, Christine Kandell, Anne Moreau, Karine Renaudin, Anne Cesbron, Florent Delbos, Alexandre Walencik, Anne Devis, Lucile Amrouche, Dany Anglicheau, Olivier Aubert, Lynda Bererhi, Christophe Legendre, Alexandre Loupy, Frank Martinez, Rébecca Sberro-Soussan, Anne Scemla, Claire Tinel, Julien Zuber, Pascal Eschwege, Luc Frimat, Sophie Girerd, Jacques Hubert, Marc Ladriere, Emmanuelle Laurain, Louis Leblanc, Pierre Lecoanet, Jean-Louis Lemelle, Lionel Badet, Maria Brunet, Fanny Buron, Rémi Cahen, Sameh Daoud, Coralie Fournie, Arnaud Grégoire, Alice Koenig, Charlène Lévi, Emmanuel Morelon, Claire Pouteil-Noble, Thomas Rimmelé, Olivier Thaunat, Sylvie Delmas, Valérie Garrigue, Moglie Le Quintrec, Vincent Pernin, Jean-Emmanuel Serre.
Author information
Authors and Affiliations
Consortia
Contributions
Samuel Frey, Lucile Figueres, and Éric Mirallié participated in study conception, drafting of manuscript, and critical revision of manuscript. Thomas Goronflot, Matthieu Wargny, and Pierre-Antoine Gourraud made the statistical analysis and participated in the acquisition and interpretation of data. Clarisse Kerleau, Claire Blanchard, Cécile Caillard, and Maryvonne Hourmant participated in acquisition of data and critical revision of manuscript.
Corresponding author
Ethics declarations
Ethics approval
The French DIVAT cohort was approved by the CNIL, n°914184.
Consent to participate
All participants gave informed consent.
Consent for publication
All authors approved the last version of the manuscript and gave their consent for publication.
Conflict of interest
PA Gourraud is the founder (2008) (www.methodomics.com) and the co-founder of Wedata (2018) (www.wedata.science). He is consulting for major pharmaceuticals companies all dealt with through academic pipelines (AstraZeneca, Biogen, Boston Scientific, Cook, Edimark, Ellipses, Elsevier, Methodomics, Merck, Mérieux, Sanofi-Genzyme, WeData). He has no prescription activity neither drugs nor devices. The other authors have no conflicts of interest to disclose.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Frey, S., Goronflot, T., Blanchard, C. et al. Impact of parathyroidectomy on kidney graft function in post-transplant tertiary hyperparathyroidism: a comparative study. Langenbecks Arch Surg 407, 2489–2498 (2022). https://doi.org/10.1007/s00423-022-02555-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-022-02555-z